Framatome to produce Lu-177 at Romania’s Cernavoda

November 18, 2024, 9:30AMNuclear News
Bernard Fontana (left) of Framatome and Cosmin Ghiță of Nuclearelectrica. (Photo: Framatome)

Framatome and SN Nuclearelectrica, a partially state-owned Romanian nuclear energy company, have entered into a long-term cooperation agreement to produce the medical isotope lutetium-177 at Cernavoda nuclear power plant in Romania. Lu-177 is a beta-emitting radioisotope used in targeted radionuclide therapy for the treatment of neuroendocrine tumors and prostate cancer.

To continue reading, log in or create a free account!

Related Articles

ANSTO-designed target increases Mo-99 yield

February 25, 2026, 1:00PMNuclear News

The Australian Nuclear Science and Technology Organization (ANSTO) announced that it has made progress on a more cost-effective way to produce the medical radioisotope molybdenum-99, with less...

Flamanville-3 reaches full power

December 17, 2025, 3:03PMNuclear News

France’s state-owned electric utility EDF has announced that Flamanville-3—the country’s first EPR—reached full nuclear thermal power for the first time, generating 1,669 megawatts of...